111 related articles for article (PubMed ID: 745402)
1. Steroidal inhibitors of prostatic 5alpha-reductase: structure-activity relationships.
Dupuy GM; Roberts KD; Bleau G; Chapdelaine A
J Steroid Biochem; 1978 Nov; 9(11):1043-7. PubMed ID: 745402
[No Abstract] [Full Text] [Related]
2. Studies on a 5 alpha-reductase inhibitor and their therapeutic implications.
Petrow V; Lack L
Prog Clin Biol Res; 1981; 75B():283-97. PubMed ID: 7323098
[No Abstract] [Full Text] [Related]
3. 5alpha-reduction of an anti-androgen TSAA-291, 16beta-ethyl-17beta-hydroxy-4-estren-3-one, by nuclear 5alpha-reductase in rat prostates.
Sudo K; Yoshida K; Akinaga Y; Nakayama R
Steroids; 1981 Jul; 38(1):55-71. PubMed ID: 7292540
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of prostatic 5alpha-reductase and 3alpha-hydroxysteroid dehydrogenase by two antiandrogens.
Dupuy GM; Roberts KD; Bleau G; Chapdelaine A
J Steroid Biochem; 1977 Nov; 8(11):1145-51. PubMed ID: 926781
[No Abstract] [Full Text] [Related]
5. Inhibitory effects of some steroidal 6-methylene derivatives on 5 alpha-reductase activity in human and rat prostate.
Kadohama N; Petrow V; Lack L; Sandberg AA
J Steroid Biochem; 1983 May; 18(5):551-8. PubMed ID: 6855230
[TBL] [Abstract][Full Text] [Related]
6. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
7. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.
Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH
Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948
[TBL] [Abstract][Full Text] [Related]
8. Prostatic cancer--II. Inhibitors of rat prostatic 4-ene-3-ketosteroid 5 alpha-reductase derived from 6-methylene-4-androsten-3-ones.
Petrow V; Wang YS; Lack L; Sandberg A; Kadohama N; Kendle K
J Steroid Biochem; 1983 Oct; 19(4):1491-502. PubMed ID: 6645489
[TBL] [Abstract][Full Text] [Related]
9. Prostatic cancer. I. 6-Methylene-4-pregnen-3-ones as irreversible inhibitors of rat prostatic delta 4-3 ketosteroid 5 alpha-reductase.
Petrow V; Wang Y; Lack L; Sandberg A
Steroids; 1981 Aug; 38(2):121-40. PubMed ID: 7303026
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
11. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
13. Properties of testosterone 5 -reductase of purified nuclear fraction from ventral prostate of rats.
Shimazaki J; Horaguchi T; Oki Y; Shida K
Endocrinol Jpn; 1971 Apr; 18(2):179-87. PubMed ID: 4105278
[No Abstract] [Full Text] [Related]
14. Azasteroids as inhibitors of rat prostatic 5 alpha-reductase.
Rasmusson GH; Reynolds GF; Utne T; Jobson RB; Primka RL; Berman C; Brooks JR
J Med Chem; 1984 Dec; 27(12):1690-701. PubMed ID: 6502599
[TBL] [Abstract][Full Text] [Related]
15. Preparation of 20-(hydroxymethyl)-4-methyl-4-aza-2-oxa-5 alpha-pregnan-3-one as an inhibitor of testosterone 5 alpha-reductase.
Weintraub PM; Blohm TR; Laughlin M
J Med Chem; 1985 Jun; 28(6):831-3. PubMed ID: 4009607
[TBL] [Abstract][Full Text] [Related]
16. 5alpha-reductase activity in the prostate.
Steers WD
Urology; 2001 Dec; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds.
Nnane IP; Kato K; Liu Y; Long BJ; Lu Q; Wang X; Ling YZ; Brodie A
Endocrinology; 1999 Jun; 140(6):2891-7. PubMed ID: 10342882
[TBL] [Abstract][Full Text] [Related]
18. A novel class of inhibitors for human steroid 5alpha-reductase: synthesis and biological evaluation of indole derivatives. II.
Igarashi S; Inami H; Hara H; Fujii M; Koutoku H; Oritani H; Mase T
Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):382-8. PubMed ID: 10726862
[TBL] [Abstract][Full Text] [Related]
19. 6-Substituted 3,4-dihydro-naphthalene-2-carboxylic acids: synthesis and structure-activity studies in a novel class of human 5alpha reductase inhibitors.
Baston E; Salem OI; Hartmann RW
J Enzyme Inhib Med Chem; 2002 Oct; 17(5):303-20. PubMed ID: 12683747
[TBL] [Abstract][Full Text] [Related]
20. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
